Thrombotic thrombocytopenic purpura;Púrpura trombótica trombocitopénica

Medicina Clinica

Volumn 136, Issue 12, 2011, Pages 534-540

  De La Rubia, Javier ^a,b   Contreras, Enric ^c   Del Río Garma, Julio ^d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^d Nephrology Department   (Spain)

Author keywords

Clinics; Physiopathology; Thrombotic thrombocytopenic purpura; Treatment

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; DISEASE COURSE; FOLLOW UP; HUMAN; LABORATORY; MICROCIRCULATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PLASMAPHERESIS; RELAPSE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 79955015412     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.02.011     Document Type: Review

References (60)

1. E. Moschcowitz An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries Arch Intern Med 36 1925 89 93
2. K. Fujikawa, H. Suzuki, B. McMullen, and D. Chung Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family Blood 98 2001 1662 1666
3. D.R. Terrell, L.A. Williams, S.K. Vesely, B. Lämmle, J.A. Hovinga, and J.N. George The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: All patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency J Thromb Haemost 3 2005 1432 1436 (Pubitemid 41725200)
4. R.L. Ridolfi, and W.R. Bell Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature Medicine (Baltimore) 60 1981 413 428 (Pubitemid 12207235)
5. R.J. Murria, and J.A. Murria Thrombotic thrombocytopenic purpura: Aetiology, pathophysiology and treatment Blood Rev 20 2006 51 60
6. J.L. Moake Journey in reverse: TTP from bedside to blood bank to bench J Clin Aph 22 2007 37 49 (Pubitemid 46407060)
7. A. Veyradier, J.M. Lavergne, A.S. Ribba, B. Obert, C. Loirat, and D. Meyer Ten candidate ADAMTS13 mutations in six French families with congenital thrombocytopenic purpura (Upshaw-Schulman syndrome) J Thromb Haemost 2 2004 424 429 (Pubitemid 40185653)
8. G. Baehr, P. Klemperer, and A. Schifrin An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles Trans Assoc Am Phys 65 1936 45 58
9. E.L. Amorosi, and J.E. Ultmann Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature Medicine (Baltimore) 45 1966 139 159
10. G. Rock, J.G. Kelton, K.H. Shumak, N.A. Buskard, D.M. Sutton, and W.B. Benny Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group Br J Haematol 103 1998 1031 1036 (Pubitemid 29012639)
11. J. Cuttner Thrombotic thrombocytopenic purpura: A ten year experience Blood 56 1980 302 306 (Pubitemid 10043432)
12. H. Olsen Thrombotic thrombocytopenic purpura as a cause of pancreatitis: Report of a case and review of the literature Dig Dis 18 1973 238 246
13. M.D. Bell, J.S. Barnhart Jr, and J.M. Martin Thrombotic thrombocytopenic purpura causing sudden unexpected death a series of 8 patients Am J Forensic Sci 35 1990 601 613 (Pubitemid 20151965)
14. R.L. Ridolfi, G.M. Hutchins, and W.R. Bell The heart and cardiac conduction system in thrombotic thrombocytopenic purpura: A clinicopathologic study of 17 autopsied patients Ann Intern Med 91 1979 357 363 (Pubitemid 10220773)
15. K.H. Shumak, G.A. Rock, R.C. Nair Canadian Apheresis Group Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura Ann Intern Med 122 1995 569 572
16. M. Furlan, R. Robles, M. Solenthaler, M. Wassmer, P. Sandoz, and B. Lammle Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura Blood 89 1997 3097 3103 (Pubitemid 27229791)
17. J.E. Sadler, J.L. Moake, T. Miyata, and J.N. George Recent advances in thrombotic thrombocytopenic purpura Hematology 2004 407 423
18. J.R. Schriber, and G.P. Herzig Transplantation-associated thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome Sem Hematol 34 1997 126 133 (Pubitemid 27175070)
19. C.L. Bennett, C.J. Davidson, D.W. Raisch, P.D. Weinberg, R.H. Bennett, and M.D. Feldman Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention Arch Intern Med 159 1999 2524 2528
20. J.L. Gottschall, B. Neahring, J.G. McFarland, G.G. Wu, L.A. Weitekamp, and R.H. Aster Quinine-induced immune thrombocytopenia with hemolytic uremia syndrome: Clinical and serological findings in nine patients and review of literature Am J Hematol 47 1994 283 289 (Pubitemid 24372282)
21. A. Zarifian, S. Meleg-Smith, R. O'Donovan, R.J. Tesi, and V. Batuman Cyclosporine-associated thrombotic microangiopathy in renal allografts Kidney Int 55 1999 2457 2466 (Pubitemid 29256501)
22. M.C. Fung, A.M. Storniolo, B. Nguyen, M. Arning, W. Brookfield, and J. Vigil A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 1999 2023 2032 (Pubitemid 29202779)
23. A.N. Leaf, L.J. Laubenstein, B. Raphael, H. Hochster, L. Baez, and S. Karpatkin Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection Ann Intern Med 109 1988 194 197
24. L.I. Gordon, and H.C. Kwaan Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura hemolytic uremic syndrome in the cancer patient Semin Thromb Hemost 25 1999 217 221 (Pubitemid 29227150)
25. J.F. Dong, J.L. Moake, and L. Nolasco ADAMTS13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions Blood 100 2002 4033 4039 (Pubitemid 35396870)
26. R. Donadelli, J.N. Orje, and C. Capoferri Size regulation of von Willebrand factormediated platelet thrombi by ADAMTS13 in flowing blood Blood 107 2006 1943 1950 (Pubitemid 43289375)
27. J. Moake Thrombotic microangiopathies N Engl J Med 347 2002 589 600
28. M. Rieger, P.M. Mannucci, J.A. Kremer Hovinga, A. Herzog, G. Gerstenbauer, and C. Konetschny ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases Blood 106 2005 1262 1267 (Pubitemid 41129589)
29. V. Bianchi, R. Robles, and L. Alberio Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura Blood 100 2002 710 713 (Pubitemid 34761143)
30. H.C. Kwaan, and C.L. Bennett Thrombotic thrombocytopenic purpura Semin Thromb Hemost 31 2005 611 614
31. F. Banno, K. Kokame, and T. Okuda Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura Blood 107 2006 3161 3166
32. H.M. Tsai Thrombotic thrombocytopenic purpura: A thrombotic disorder caused by ADAMTS13 deficiency Hematol Oncol Clin North Am 21 2007 609 632
33. P.M. Mannucci, and F. Peyvandi TTP and ADAMTS13: When is testing appropriate? Hematology 2007 121 126
34. S. Kato, M. Matsumoto, T. Matsuyama, A. Isonishi, H. Hiura, and Y. Fujimura Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS-13 activity Transfusion 46 2006 1444 1452 (Pubitemid 44117975)
35. G.A. Hosler, A.M. Cusumano, and G.M. Hutchins Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases Arch Pathol Lab Med 127 2003 834 839 (Pubitemid 36792310)
36. S. Ferrari, F. Scheiflinger, and M. Rieger On behalf of French Clinical and Biological Network on Adult Thrombotic Microangiopathies. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity Blood 109 2007 2815 2822 (Pubitemid 46482076)
37. F. Peyvandi, S. Lavoretano, R. Palla, H.B. Feys, K. Vanhoorebelke, and T. Battaglioli ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission Haematology 93 2008 232 239 (Pubitemid 351397711)
38. L.H. Nolasco, N.A. Turner, and A. Bernardo Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers Blood 106 2005 4199 4209 (Pubitemid 41775927)
39. G.A. Rock, and W.F. Clark Mechanism of microthrombosis in HUS Kidney Int 75 2009 S11 S14
40. D. Kavanagh, T.H. Goodship, and A. Richards Atypical haemolytic uraemic syndrome Br Med Bull 77 2006 5 22 (Pubitemid 46092270)
41. P. Coppo, D. Bengoufa, and A. Veyradier Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement Medicine (Baltimore) 83 2004 233 244 (Pubitemid 38955446)
42. I. Tostivint, B. Mougenot, and A. Flahault Adult haemolytic and uraemic syndrome: Causes and prognostic factors in the last decade Nephrol Dial Transplant 17 2002 1228 1234 (Pubitemid 34812067)
43. J.J. Byrnes, and M. Khurana Treatment of thrombotic thrombocytopenic purpura with plasma N Engl J Med 297 1977 1386 1389 (Pubitemid 8256298)
44. G.A. Rock, K.H. Shumak, N.A. Buskard, V.S. Blanchette, J.G. Kelton, and R.C. Nair Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325 1991 393 397
45. Z.M. Szczepiorkowski, N. Bandarenko, H.C. Kim, M.L. Linenberger, M.B. Marques, and R. Sarode Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis J Clin Apheresis 22 2007 106 175 (Pubitemid 47025120)
46. Leitman SF, Kucera E, McLeod BC. Extracorporeal Therapy Committee. Guidelines for Therapeutic Hemapheresis. American Association of Blood Banks, Bethesda, 1992
47. Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev. 2009;21:CD003595
48. T.J. Raife, K.D. Friedman, and D.M. Dwyre The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: Reconsideration of treatment with cryopoor plasma Transfusion 46 2006 74 79 (Pubitemid 43381787)
49. J. Del Río, A. Álvarez, C. Martínez, J. Muncunill, D. Castellà, and J. De la Rubia Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: A multicentric, prospective cohort study Br J Haematol 143 2008 39 45
50. S.R. Cataland, M. Jin, A.K. Ferketich, M.S. Kennedy, E.H. Kraut, and J.N. George An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura Br J Haematol 132 2006 146 149
51. W.R. Bell, H.G. Braine, P.M. Ness, and T.S. Kickler Improved survival in thrombotic thrombocytopenic purpura hemolytic uremic syndrome. Clinical experience in 108 patients N Engl J Med 325 1991 398 403
52. E. Bobbio-Pallavicini, L. Gugliotta, R. Centurioni, C. Porta, N. Vianelli, and A. Billio Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP Haematologica 82 1997 429 435 (Pubitemid 28023280)
53. M.H. Rosove, W.G. Ho, and D. Goldfinger Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura Ann Int Med 96 1982 27 33 (Pubitemid 12205511)
54. M.C. Kappers-Klunne, P. Wijermans, R. Fijnheer, A.J. Croockewit, B. Van der Holt, and J.T.M. De Wolf Splenectomy for the treatment of thrombotic thrombocytopenic purpura Br J Haematol 130 2005 768 776 (Pubitemid 43906650)
55. A. Ziman, M. Mitri, E. Klapper, S.H. Pepkowitz, and D. Goldfinger Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: One institution's experience and review of the literature Transfusion 45 2005 41 49
56. J.P. Hand, E.R. Lawlor, C.K.K. Young, and J.H. Davis Successful use of cyclosporin A in the treatment of refractory thrombotic thrombocytopenic purpura Br J Haematol 100 1998 597 599 (Pubitemid 28270501)
57. F. Fakhouri, J.P. Vernant, A. Veyradier, M. Wolf, G. Kaplanski, and R. Binaut Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13 deficient thrombotic thrombocytopenic purpura: A study of 11 cases Blood 106 2005 1932 1937 (Pubitemid 41291703)
58. M. Scully, H. Cohen, J. Cavenagh, S. Benjamin, R. Starke, and S. Killick Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13 Br J Haematol 136 2007 451 461 (Pubitemid 46046304)
59. H.T. Ling, J.J. Field, and M.A. Blinder Sustained response in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature Am J Hematol 84 2009 418 421
60. S.R. Foley, K. Webert, D.M. Arnold, G.A. Rock, W.F. Clark, and D. Barth A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura Kidney Int 75 2009 S55 S58